• SENSEX 74,151.04
    905.01 (+1.24%)
  • BANKNIFTY 54,267.40
    292.50 (+0.54%)
  • Jio Platforms
    1,490.00 1,423.80(%)
  • Reliance Industries
    1,182.00 1,611.20(%)
  • NSE
    1,795.00 1,878.00(%)
  • Tube Investments
    2,177.45 3,335.00(%)
  • PTC Industries
    24,888.20 26,049.95(%)
  • Dalmia BharatLtd
    1,403.50 1,464.85(%)
  • HDFC Bank
    678.05 668.90(%)
  • Aeroflex
    579.00 613.50(%)
  • Pidilite Inds.
    1,429.05 1,707.95(%)
  • The Bombay Burmah
    1,203.00 2,050.25(%)
  • Cholaman.Inv.&Fn
    1,618.00 1,952.00(%)
  • Bharti Airtel
    1,977.75 2,174.70(%)
  • Birlasoft Ltd
    352.25 473.75(%)
  • ICICI Bank
    1,387.55 1,479.90(%)
  • Billionbrains
    193.00 227.00(%)
  • Bajaj Finance
    943.00 1,177.60(%)
  • SBI
    980.00 1,234.80(%)
  • Adani Ports
    1,872.20 1,891.80(%)
  • Max Healthcare
    865.95 1,196.50(%)
  • Kotak Mah. Bank
    460.00 453.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Haleos Labs Limited Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 68575.0
  • ISIN : INE320X01016
1,450.60 -23 (-1.59%)
  • As on 29 Oct 2026 (EOD)

  • Today’s Low

    1,435.00

  • Today’s High

    1,474.00

  • Open

    1,474.00

  • Perv Close

    1,474.00

  • 52W Low

    1,091.10

  • 52W High

    1,774.00

Key Indicators

  • P/E(TTM)

    27.66

  • Mar.Cap (₹Cr.)

    438.56

  • Div & Yield %

    0.10

  • Book Value(₹)

    709.75

  • Debt-Equity Ratio

    -1.59

  • AGM Date

    28-Oct-2026

  • EPS

    52.45

  • P/E Ratio

    27.66

Financials Ratios

  • Debt-Equity Ratio

    0.58

  • Mar.Cap (₹Cr.)

    438.56

  • RONW (%)

    3.67

  • ROCE (%)

    7.24

Score Board

  • Equity (₹ in Cr.)

    3.02

  • BV (₹)

    709.70

  • Sales( ₹ in Cr.)

    300.99

  • NP (in Cr.)

    17.78

  • NP Var(%)

    -17.0

  • Div%

    15.0

  • CPS (₹)

    94.10

  • EPS (₹)

    58.80

  • Traded Value (₹ in Lakhs)

    438.56

  • 52 Week High

    1,774.00

  • 52 Week Low

    1,091.10

  • Price BSE

    1493.0

  • Price NSE

    1,451.00

  • Market Capital( in Cr.)

    438.56

  • P/C Ratio

    15.40

  • P/E Ratio

    24.70

  • Price Vs.BV

    58.80

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 334.51 368.35 328.75 351.88 379.12 286.88
Excise Duty 33.52 34.98 28.75 36.63 33.49 26.63
Net Sales 300.99 333.37 300.00 315.25 345.63 260.25
Other Income 1.42 3.95 3.84 5.23 14.23 1.33
Stock Adjustments 6.51 -4.69 -0.98 -0.30 7.79 -1.90
Total Income 308.92 332.63 302.86 320.18 367.65 259.68
EXPENDITURE :            
Raw Materials 148.15 164.43 161.19 189.95 216.16 137.76
Power and Fuel Cost 27.70 27.17 26.46 25.66 26.32 19.52
Employee Cost 49.39 45.78 40.92 34.72 32.51 27.11
Other Manufacturing Expenses 28.19 28.51 24.19 24.08 32.06 27.22
Selling and Administration Expenses 10.48 11.31 9.62 11.69 13.20 11.94
Miscellaneous Expenses 3.03 7.19 2.10 2.36 1.74 5.01
Employee Benefit Expenses 49.39 45.78 40.92 34.72 32.51 27.11
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 266.94 284.39 264.49 288.46 321.99 228.55
Operating Profit 41.98 48.24 38.38 31.71 45.65 31.14
Interest 6.12 7.94 9.01 5.16 4.68 4.57
Gross Profit 35.86 40.30 29.37 26.55 40.97 26.57
Depreciation 10.66 10.26 10.25 8.17 7.99 7.21
Profit Before Tax 25.20 30.04 19.12 18.38 32.98 19.36
Current Tax 5.32 8.81 4.05 3.15 7.56 5.03
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 2.09 -0.14 1.99 2.01 0.04 1.16
Reported Net Profit 17.78 21.37 13.07 13.22 25.38 13.17
Extraordinary Items 0.00 0.04 0.00 1.87 9.47 0.01
Adjusted Net Profit 17.78 21.33 13.07 11.35 15.91 13.16
Adjustment below Net Profit 0.08 0.03 -0.41 0.05 -0.05 -0.09
P & L Balance brought forward 119.98 101.03 90.83 80.02 57.14 45.06
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 2.45 2.45 2.45 2.45 2.45 1.00
P & L Balance carried down 135.38 119.98 101.03 90.83 80.02 57.14
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 15.00 15.00 15.00 15.00 15.00 15.00
Dividend Per Share(Rs) 1.50 1.50 1.50 1.50 1.50 1.50
Earnings Per Share-Unit Curr 58.80 70.69 43.22 43.72 83.95 43.56
Earnings Per Share(Adj)-Unit Curr 58.80 70.69 43.22 43.72 83.95 43.56
Book Value 709.74 652.19 582.90 542.55 500.16 417.88
Book Value(Adj)-Unit Curr 709.74 652.19 582.90 542.55 500.16 417.88

Shareholding Pattern

  • Promoter Group

    72.11%

  • Public Share Holding

    27.89%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 8,000 0.26 8,000 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 2,171,976 71.84 2,171,976 11
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 2,179,976 72.11 2,179,976 12
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 9,465 0.31 9,465 1
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 9,465 0.31 9,465 1
2] Non Institution
Bodies Corporate 98,200 3.25 98,148 57
Clearing Members 194 0.01 194 5
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 6,677 0.22 6,641 133
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 0 0.00 0 0
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 80,759 2.67 80,759 3
Individuals holding nominal share capital up to Rs. 1 lakh 647,926 21.43 640,030 6,549
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 61 0.00 0 1
Others 10 0.00 10 2
Sub Total 833,846 27.58 825,801 6,752
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 3,023,287 100.00 3,015,242 6,765

Company Background

Haleos Labs LimitedPharmaceuticals - Indian - Bulk Drugs & Formln

  • Haleos Labs Limited
  • BSE Code : 68575.0
  • ISIN : INE320X01016

  • Incorporation Year

    2006

  • Registered Office

    Plot No 19-III Road No 71
    Opp Bharatiya Vidya Bhavan PSc, Hyderabad,
    Telangana-500096

  • Telephone

    91-040-6628-8888

  • FAX

    91-040-2355-1401

  • Chairman

  • Managing Director

    T V V S N Murthy

  • Company Secretary

    Trupti Ranjan Mohanty

  • Auditor

    Rambabu & Co

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    Aarthi Consultants Pvt Ltd
    1-2-285 Domalguda,
    ,
    Mumbai - Hyderabad - 500 029

Haleos Labs Limited Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Haleos Labs Limited 1,450.60 302.41 334.51 27.66 10.50
Abbott India 26,278.90 7,217.19 6,929.05 34.58 43.78
Astrazeneca Phar 6,234.70 2,304.07 2,275.58 91.89 27.86
Glaxosmi. Pharma 2,496.65 3,932.76 3,790.20 39.88 58.17
Novartis India 1,805.95 393.10 354.33 45.60 15.94
Cipla 1,360.00 20,102.60 18,979.95 41.45 13.88
Bliss GVS Pharma 650.05 773.53 729.81 60.41 12.51
Amrutanjan Healt 491.10 520.13 502.55 26.30 24.16
Fermenta Biotec. 443.85 474.15 450.25 20.72 18.77
Guj. Themis Bio. 355.25 168.25 165.82 94.99 18.05
Ambalal Sarabhai 35.73 19.52 3.94 66.17 6.77